Literature DB >> 26664002

Prediction of Poor Ovarian response by Biochemical and Biophysical Markers: A Logistic Regression Model.

S P Jaiswar1, S M Natu2, P L Sankhwar1, Gupta Manjari1.   

Abstract

OBJECTIVES: To study correlation between ovarian reserve with biophysical markers (antral follicle count and ovarian volume) and biochemical markers (S. FSH, S. Inhibin B, and S. AMH) and use these markers to predict poor ovarian response to ovarian induction.
METHODS: This is a prospective observational study. One hundred infertile women attending the Obst & Gynae Dept, KGMU were recruited. Blood samples were collected on day 2/day 3 for assessment of S. FSH, S. Inhibin B, and S. AMH and TVS were done for antral follicle count and ovarian volume. Clomephene citrate 100 mg 1OD was given from day 2 to 6, and patients were followed up with serial USG measurements. The numbers of dominant follicles (> or = 14 mm) at the time of hCG administration were counted. Patients with <3 follicles in the 1st cycle were subjected to the 2nd cycle of clomephene 100 mg 1OD from day 2 to day 6 with Inj HMG 150 IU given i.m. starting from day 8 and every alternate day until at least one leading follicle attained ≥18 mm. Development of <3 follicles at end of the 2nd cycle was considered as poor response.
RESULTS: Univariate analyses showed that s. inhibin B presented the highest (ROCAUC = 0.862) discriminating potential for predicting poor ovarian response, In multivariate logistic regression model, the variables age, FSH, AMH, INHIBIN B, and AFC remained significant, and the resulting model showed a predicted accuracy of 84.4 %.
CONCLUSION: A derived multimarker computation by a logistic regression model for predicting poor ovarian response was obtained through this study. Thus, potential poor responders could be identified easily, and appropriate ovarian stimulation protocol could be devised for such pts.

Entities:  

Keywords:  Anti-mullerian hormone; Antral follicle count; Inhibin B; Logistic regression analysis; Poor responders

Year:  2014        PMID: 26664002      PMCID: PMC4666210          DOI: 10.1007/s13224-014-0639-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  8 in total

1.  Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3.

Authors:  C H Syrop; J D Dawson; K J Husman; A E Sparks; B J Van Voorhis
Journal:  Hum Reprod       Date:  1999-07       Impact factor: 6.918

2.  Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy.

Authors:  N P Johnson; E M Bagrie; A Coomarasamy; S Bhattacharya; A N Shelling; S Jessop; C Farquhar; K S Khan
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

3.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.

Authors:  J P Toner; C B Philput; G S Jones; S J Muasher
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

4.  Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome.

Authors:  M Creus; J Peñarrubia; F Fábregues; E Vidal; F Carmona; R Casamitjana; J A Vanrell; J Balasch
Journal:  Hum Reprod       Date:  2000-11       Impact factor: 6.918

5.  Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?

Authors:  Shanthi Muttukrishna; Harris Suharjono; Hugh McGarrigle; Muttukrishna Sathanandan
Journal:  BJOG       Date:  2004-11       Impact factor: 6.531

6.  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.

Authors:  A P Ferraretti; A La Marca; B C J M Fauser; B Tarlatzis; G Nargund; L Gianaroli
Journal:  Hum Reprod       Date:  2011-04-19       Impact factor: 6.918

7.  The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization.

Authors:  Ellen R Klinkert; Frank J M Broekmans; Caspar W N Looman; J Dik F Habbema; Egbert R te Velde
Journal:  Fertil Steril       Date:  2005-03       Impact factor: 7.329

8.  Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.

Authors:  Eman A Elgindy; Dahlia O El-Haieg; Azza El-Sebaey
Journal:  Fertil Steril       Date:  2007-07-20       Impact factor: 7.329

  8 in total
  4 in total

1.  MOTHER Study: A Multicenter Observational, Retrospective Study to Determine Coorelation Between Physical CHaracteristics and Ovarian REserve Markers in Sub-feRtile Women.

Authors:  Charmila Ayyavoo; Asha Baxi; Gorakh Mandrupkar; Sonia Malik; Jayam Kannan; Deepak Goenka; Nagesh Kumar; Monica Singh; Sharda Kulkarni; Kanchan Murarka Agarwal; Sonam Baxi
Journal:  J Obstet Gynaecol India       Date:  2021-05-08

2.  Acupuncture for Poor Ovarian Response: A Randomized Controlled Trial.

Authors:  Jihyun Kim; Hoyoung Lee; Tae-Young Choi; Joong Il Kim; Byoung-Kab Kang; Myeong Soo Lee; Jong Kil Joo; Kyu Sup Lee; Sooseong You
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

3.  A randomized, open phase IV exploratory clinical trial to evaluate the efficacy and safety of acupuncture on the outcome of induction of ovulation in women with poor ovarian response: A study protocol for a randomized controlled trial.

Authors:  Hoyoung Lee; Tae-Young Choi; Eun Hyoung Shim; Jiae Choi; Jong Kil Joo; Bo Sun Joo; Myeong Soo Lee; Jun-Yong Choi; Ki-Tae Ha; Sooseong You; Kyu Sup Lee
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  Effect of acupuncture on women with poor ovarian response: a study protocol for a multicenter randomized controlled trial.

Authors:  Huanfang Xu; Chensi Zheng; Liyun He; Tongsheng Su; Huidan Wang; Yu Li; Cui Zhao; Cuilian Zhang; Yang Bai; Guoqing Tong; Li Chen; Fang Zhao; Huisheng Yang; Mingzhao Hao; Yaqian Yin; Li Yang; Yigong Fang; Baoyan Liu
Journal:  Trials       Date:  2020-09-10       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.